chr22-32154268-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010859.3(C22orf42):c.283G>A(p.Gly95Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,610,894 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001010859.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C22orf42 | NM_001010859.3 | c.283G>A | p.Gly95Arg | missense_variant | 2/9 | ENST00000382097.4 | NP_001010859.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C22orf42 | ENST00000382097.4 | c.283G>A | p.Gly95Arg | missense_variant | 2/9 | 1 | NM_001010859.3 | ENSP00000371529.3 | ||
C22orf42 | ENST00000467813.1 | n.390G>A | non_coding_transcript_exon_variant | 2/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000133 AC: 31AN: 232776Hom.: 0 AF XY: 0.0000871 AC XY: 11AN XY: 126246
GnomAD4 exome AF: 0.000137 AC: 200AN: 1458712Hom.: 0 Cov.: 30 AF XY: 0.000117 AC XY: 85AN XY: 725516
GnomAD4 genome AF: 0.000158 AC: 24AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.283G>A (p.G95R) alteration is located in exon 2 (coding exon 2) of the C22orf42 gene. This alteration results from a G to A substitution at nucleotide position 283, causing the glycine (G) at amino acid position 95 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at